Ocugen (OCGN) Cash from Operations Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.77% |
| Dec 31, 2025 | -26.66% |
| Sep 30, 2025 | -37.24% |
| Jun 30, 2025 | -28.30% |
| Mar 31, 2025 | -32.80% |
| Dec 31, 2024 | -3.46% |
| Sep 30, 2024 | -39.70% |
| Jun 30, 2024 | -24.13% |
| Mar 31, 2024 | -31.77% |
| Dec 31, 2023 | -32.32% |
| Sep 30, 2023 | -14.65% |
| Jun 30, 2023 | -29.25% |
| Mar 31, 2023 | -49.83% |
| Dec 31, 2022 | -31.39% |
| Sep 30, 2022 | -20.09% |
| Jun 30, 2022 | -19.64% |
| Mar 31, 2022 | -15.45% |
| Dec 31, 2021 | -16.79% |
| Sep 30, 2021 | -8.09% |
| Jun 30, 2021 | -27.22% |
| Mar 31, 2021 | 7.59% |
| Dec 31, 2020 | 9.35% |
| Sep 30, 2020 | 17.36% |
| Jun 30, 2020 | 16.19% |
| Mar 31, 2020 | 11.62% |
| Dec 31, 2019 | -13.33% |
| Sep 30, 2019 | 5.39% |
| Jun 30, 2019 | 9.19% |
| Mar 31, 2019 | 11.88% |